Found 8 matching trials
Individualized Comprehensive Treatment for Advanced Hepatocellular Carcinoma NA This project is a prospective, multi-center, multi-cohort exploratory clini...
Show More Location
China Pharmaceutical University Affiliated Nanjing Tianyinshan Hospital
Learn More & Join Trial
Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular Carcinoma PHASE2 The investigators design a phase II clinical study to explore the efficacy ...
Show More Location
Multiple Locations
Learn More & Join Trial
Single-Arm Clinical Study of Icaritin Soft Capsules as Adjuvant Therapy for Hepatocellular Carcinoma Patients at High Risk of Postoperative Recurrence PHASE2 Observing the Efficacy and Safety of Icaritin Soft Capsules as Postoperativ...
Show More Status
Active Not Recruiting
Location
the Second Affiliated Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors PHASE2 This is a single-center, single-arm, prospective trial to explore the effic...
Show More Location
Clinical Medical College of Yangzhou University
Learn More & Join Trial
Icaritin in Combination With AG in Patients With Previously Untreated Advanced Pancreatic Ductal Adenocarcinoma PHASE2 Icaritin is a drug that has been approved by the National Medical Products ...
Show More Location
Sun Yat-sen Memorial Hospital
Learn More & Join Trial
Icaritin Soft Capsule Versus Huachansu Tablet in the First-line Treatment of Unresectable Hepatocellular Carcinoma With Poor Conditions and Biomarker Enrichment (Biomarker Enrichment Study of Poor Prognosis HCC Patients, BESTPOP) PHASE3 A study to evaluate the efficacy and safety of icaritin versus huachansu in...
Show More Location
The Second Affiliated Hospital of Nanchang University
Learn More & Join Trial
Exploration of Sintilimab + Bevacizumab + AG Chemotherapy as First-Line Treatment for Unresectable Advanced/Metastatic Cholangiocarcinoma PHASE2 Evaluation of Efficacy and Safety of Sintilimab Plus Bevacizumab and AG Reg...
Show More Location
the Second Affiliated Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
Icaritin Soft Capsules+TACE+Immunotherapy+Targeted Therapy Versus TACE+Immunotherapy+Targeted Therapy for Unresectable Hepatocellular Carcinoma PHASE1 Hepatocellular carcinoma (HCC) is one of the most common malignant tumors a...
Show More Learn More & Join Trial